Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.6K Buy
429
+33
+8% +$3.27K ﹤0.01% 817
2026
Q1
$37.3K Buy
396
+29
+8% +$2.89K ﹤0.01% 813
2025
Q4
$36.2K Buy
367
+13
+4% +$1.26K ﹤0.01% 834
2025
Q3
$30K Buy
+354
New +$28K ﹤0.01% 743
2025
Q2
Sell
-116
Closed -$7.02K 751
2025
Q1
$7.02K Buy
116
+31
+36% +$2.16K ﹤0.01% 960
2024
Q4
$5.87K Buy
85
+4
+5% +$285 ﹤0.01% 1011
2024
Q3
$5.35K Buy
81
+9
+13% +$574 ﹤0.01% 1092
2024
Q2
$4.37K Buy
72
+33
+85% +$1.87K ﹤0.01% 1108
2024
Q1
$2.22K Sell
39
-16
-29% -$960 ﹤0.01% 1216
2023
Q4
$3.45K Buy
55
+44
+400% +$2.49K ﹤0.01% 1130
2023
Q3
$635 Hold
11
﹤0.01% 1267
2023
Q2
$685 Sell
11
-28
-72% -$1.87K ﹤0.01% 1256
2023
Q1
$2.82K Hold
39
﹤0.01% 1126
2022
Q4
$3.13K Hold
39
﹤0.01% 1088
2022
Q3
$3K Hold
39
﹤0.01% 1047
2022
Q2
$3K Buy
39
+6
+18% +$456 ﹤0.01% 1015
2022
Q1
$3K Buy
+33
New +$2.4K ﹤0.01% 1107

Other funds holding INCY

Quent Capital's INCY Position: Q2 2026 in Review

Quent Capital increased its Incyte (INCY) stake by 8.3% in Q2 2026, buying an estimated $3.27K and bringing the position to 429 shares worth $48.6K. The position accounts for ﹤0.01% of the portfolio, ranked #817.

Quent Capital first reported a position in INCY in Q1 2022 and has held it in 17 quarters since. 859 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Quent Capital held 429 shares of Incyte worth $48.6K as of Q2 2026.
  • Quent Capital bought 33 Incyte shares in Q2 2026, an estimated $3.27K.
  • Incyte made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #817 holding.
  • Quent Capital first reported a position in Incyte in Q1 2022 and has held it in 17 quarters since.
  • 859 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.